Nutritional Management of Nephrolithiasis in Chronic Kidney Disease

  • Haewook HanEmail author
  • Pamela S. Kent
  • Judith A. Beto
Part of the Nutrition and Health book series (NH)


This chapter reviews the nutritional management of nephrolithiasis in chronic kidney disease (CKD). Nutritional management of CKD is well documented and recommended by the National Kidney Foundation (NKF) and Kidney Disease Outcome Quality Initiative (KDOQI). Overall recommendation for prevention of nephrolithiasis was developed by the American Urological Association (AUA) in 2014. CKD patients with nephrolithiasis need specific nutritional management to prevent recurrence of stones and meet adequate nutritional status for CKD. Nutrition assessment, drug-nutrient interactions, and nutrition recommendations should be individualized based on the different types of stones and CKD stage.


Chronic kidney disease (CKD) Nephrolithiasis 24-hour urine test Nutrition assessment Nutrition recommendations Renin-angiotensin-aldosterone system (RAAS) inhibitors Calcium stones Uric acid stones Cystine stones 


  1. 1.
    United States Renal Data System. 2017 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017.Google Scholar
  2. 2.
    Grieff M, Bushinsky DA. Nutritional prevention and treatment of kidney stones. In: Kopple JD, Massry SG, Kalantar-Zadeh K, editors. Nutritional management of renal disease. Philadelphia: Academic Press; 2013.Google Scholar
  3. 3.
    Pfau A, Knauf F. Update on nephrolithiasis: core curriculum 2016. Am J Kidney Dis. 2016;68(6):973–85.CrossRefGoogle Scholar
  4. 4.
    Prezioso D, Strazzulio P, Lotti T, et al. Dietary treatment of urinary risk factors for renal stone formation: a review of CLU working group. Arch Ital Urol Androl. 2015;7:105–20.CrossRefGoogle Scholar
  5. 5.
    Sorensen MD, Kahn AJ, Reiner AP, WHI Working Group, et al. Impact of nutritional factors on incident kidney stones formation: a report from the WHI OS. J Urol 2012;187:1645–49.Google Scholar
  6. 6.
    Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRefGoogle Scholar
  7. 7.
    Beto JA, Ramirez WE, Bansal VK. Medical nutrition therapy in adults with chronic kidney disease: integrating evidence and consensus into practice for the generalist registered dietitian nutritionist. J Acad Nutr Diet. 2014;114:1077–87.CrossRefGoogle Scholar
  8. 8.
    Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med. 2017;377:1765–76.CrossRefGoogle Scholar
  9. 9.
    National kidney foundation kidney disease outcomes quality initiative (KDOQI) clinical practice guidelines for nutrition in chronic renal failure. Kopple JD. Am J Kidney Dis. 2000;35(6) supp 2:S1–40.Google Scholar
  10. 10.
    McCann L, editor. Council on renal nutrition. Pocket guide to nutrition assessment of the patient with kidney disease. 5th ed. New York: National Kidney Foundation; 2015.Google Scholar
  11. 11.
    Byham-Gray L, Stover J, Wiesen K, editors. A clinical guide to nutrition care in kidney disease. 2nd ed. Chicago: Academy of Nutrition and Dietetics; 2013.Google Scholar
  12. 12.
    Heilberg IP, Goldfarb DS. Optimum nutrition for kidney stone disease. Adv Chronic Kidney Dis. 2013;20:165–74.CrossRefGoogle Scholar
  13. 13.
    Parks JH, Goldfisher E, Asplin JR, Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002;167:1607–12.CrossRefGoogle Scholar
  14. 14.
    Tondin de Oliveira LM, Hauschild DB, Leite C, Baptista DR, Carvalho M. Adequate dietary intake and nutritional status in patients with nephrolithiasis: new targets and objectives. J Ren Nutr. 2014;24:417–22.CrossRefGoogle Scholar
  15. 15.
    Asplin J, Parks J, Lingeman J, et al. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998;159:1821–5.CrossRefGoogle Scholar
  16. 16.
    Asplin JR. Evaluation of the kidney stone patient. Semin. Nephrol. 2008;28:99–110.CrossRefGoogle Scholar
  17. 17.
    Chumlea WC, Guo SS, Wholihan K, et al. Stature prediction equations for elderly non-Hispanic White, non-Hispanic Black and Mexican American persons: from NHANES III (1988–1994). J Am Diet Assoc. 1998;98:137–42.CrossRefGoogle Scholar
  18. 18.
    Chumlea WC, Guo SS, Steinbaugh ML. The prediction of stature from knee height for black and white adults and children with application to mobility impaired. J Am Diet Assoc. 1994;94:1385–1388, 1391.CrossRefGoogle Scholar
  19. 19.
    Chumlea WC, Wisemandle WA, Guo SS, et al. Relations between frame size and body composition and bone mineral status. Am J Clin Nutr. 2002;75:1012–6.CrossRefGoogle Scholar
  20. 20.
    Chumnea WC. Anthropometric measurement of nutritional status in renal disease. J Renal Nutr. 1997;7:176–81.CrossRefGoogle Scholar
  21. 21.
    Eknoyan G, Levey A, Beck G, et al. The hemodialysis (HEMO) study rationale for selection of interventions. Semin Dial. 1996;9:24–33.CrossRefGoogle Scholar
  22. 22.
    Klahr S, Level A, Beck G, for the Modification of Diet in Renal Disease Study Group, et al. The effect of dietary protein restriction and blood pressure control on the progression of chronic kidney disease. N Engl J Med. 1994;330:877–84.CrossRefGoogle Scholar
  23. 23.
    Lohman TG, Roche AF, Matorell R, editors. Anthropometric standardization reference manual. Champaign: Human Kinetics Publishers; 1998.Google Scholar
  24. 24.
    USDHHS. NHANES III anthropometric procedures (videotape). Washington, D.C.; 1996.Google Scholar
  25. 25.
    Fouque D, Kalantar-Zadeh K, Kopple JD, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–3984.CrossRefGoogle Scholar
  26. 26.
    Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab. 1990;71:861–7.CrossRefGoogle Scholar
  27. 27.
    Seeger H, Kaelin A, Ferraro PM, et al. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss stone formers. BMC Nephrol. 2017;18:349.CrossRefGoogle Scholar
  28. 28.
    Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008;35:369–39.CrossRefGoogle Scholar
  29. 29.
    Borghi L, Guerra A, Meschi T, et al. Relationship between supersaturation and calcium oxalate crystallization in normal and idiopathic calcium oxalate stone formers. Kidney Int. 1999;55:1041–50.CrossRefGoogle Scholar
  30. 30.
    Chicago: Litholink Corporation; 2018. (Lab value parameters: check reference info).Google Scholar
  31. 31.
    Ferraro PM, Curhan GC. Uric acid and risk of kidney stones. Am J Kidney Dis. 2017;70:158–9.CrossRefGoogle Scholar
  32. 32.
    Curhan GC, Curhan SG. Dietary factors and kidney stone formation. Compr Ther. 1994;20:485–9.PubMedGoogle Scholar
  33. 33.
    Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North AM. 2002;31:979.CrossRefGoogle Scholar
  34. 34.
    Kang DE, Sur RL, Haleblian GE, et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007;177:1358.CrossRefGoogle Scholar
  35. 35.
    Ryall RL. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol. 1997;15:155.CrossRefGoogle Scholar
  36. 36.
    Curhan GC. Dietary calcium, dietary protein, and kidney stone formation. Miner Electrolyte Metab. 1997;23:261–4.PubMedGoogle Scholar
  37. 37.
    Curhan GC, Willett W, Speizer F, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126:497–504.CrossRefGoogle Scholar
  38. 38.
    Kim S, Chang Y, Yun KE, et al. Development of nephrolithiasis in asympotomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70:173–81.CrossRefGoogle Scholar
  39. 39.
    Rahman F, Birowo P, Widyahening IS, Rasyid N. Effect of citrus-based products on urine profile: A systematic review and meta-analysis. F1000 Res. 2017;6:220. Scholar
  40. 40.
    Fink HA, Wilt TJ, Eidman KE, et al. Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies: comparative effectiveness review no. 61, AHRQ publication no. 12-EHc049-EF, Rockville: Agency for Healthcare Research and Quality; 2012. Revised March 2013.Google Scholar
  41. 41.
    Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: American Urology Association (AUA) guideline. J Urol. 2014;192:316–24.CrossRefGoogle Scholar
  42. 42.
    Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stamphfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240–7.CrossRefGoogle Scholar
  43. 43.
    Curhan GC, Willett WC, Speizer FE, Stamphfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128:534–40.CrossRefGoogle Scholar
  44. 44.
    Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Caffeine intake and the risk of kidney stones. Am J Clin Nutr. 2014;100:1596–603.CrossRefGoogle Scholar
  45. 45.
    Ferraro PM, Taylor EN, Gambaro G, et al. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8:1389.CrossRefGoogle Scholar
  46. 46.
    Nouvenne A, Meschi T, Prati B, et al. effects of low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: 3-mo randomized controlled trial. AJCN. 2010;91:565.CrossRefGoogle Scholar
  47. 47.
    Jaeger P, Portman L, Saunders A, et al. Anticystinuric effects of glutamine and dietary sodium restriction. N Engl J Med. 1986;315(315):1120.CrossRefGoogle Scholar
  48. 48.
    Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77–84.CrossRefGoogle Scholar
  49. 49.
    Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198–204.CrossRefGoogle Scholar
  50. 50.
    Escribano J, Balaguer A, Roque Figulis M, Feliu A, Ferre N. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2014;11:CD006022.Google Scholar
  51. 51.
    Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.CrossRefGoogle Scholar
  52. 52.
    Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J Urol. 1996;155:1847–51.CrossRefGoogle Scholar
  53. 53.
    Zuckerman JM, Assimos DG. Hypercitraturia: pathophysiology and medical management. Rev Urol. 2009;11:134.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Gambaro G, Croppi E, Coe F, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715–34.CrossRefGoogle Scholar
  55. 55.
    Lemann J Jr, Worcester EM, Gray RW. Hypercalciuria and stones. Am J Kidney Dis. 1991;17:386–91. (BMD and Ca).CrossRefGoogle Scholar
  56. 56.
    Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008;28:120–32.CrossRefGoogle Scholar
  57. 57.
    Asplin JR. Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am. 2002;31:927–49.CrossRefGoogle Scholar
  58. 58.
    Prot-Bertoye C, Lebbah S, Daudon M, et al. Chronic kidney disease and its risk factors among patients with cystinuria. Clin J Am Soc Nephrol. 2015;10:842–51.CrossRefGoogle Scholar
  59. 59.
    Rodriguez LM, Santos F, Malaga S, et al. Effect of low sodium diet on urinary elimination of cysteine in cystinuric children. Nephron. 1995;71:416.CrossRefGoogle Scholar
  60. 60.
    DASH Diet. 2015. Accessed 15 April 2018.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NephrologyHarvard Vanguard Medical AssociatesBostonUSA
  2. 2.ESCP OperationsCenters for Dialysis CareShaker HeightsUSA
  3. 3.Division of Nephrology and HypertensionLoyola University of Chicago, Health Sciences DivisionMaywoodUSA

Personalised recommendations